Harpoon Therapeutics Updates Information for its Participation in Two Upcoming Virtual Conferences

NEXT STORY
Replimune to Participate at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
PREV STORY
Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release Syndrome in Hospitalized Patients with COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sucampo to Host 2017 R&D Day on November 16 in New York

ROCKVILLE, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a ...

author_avatar
NASDAQ Market News

Cytokinetics, Inc. Reports First Quarter 2016 Financial Results

SOUTH SAN FRANCISCO, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) reported ...

author_avatar
NASDAQ Market News

Clinical Trial Management System Market to Garner US$1.8 bn by 2019 – Persistence Market Research

Global Clinical Trial Management System Market Boosted by Increased Clinical Research OutsourcingNew York, June ...

author_avatar
NASDAQ Market News